ANEB
Price
$1.12
Change
-$0.08 (-6.67%)
Updated
Dec 26 closing price
Capitalization
46.01M
40 days until earnings call
Intraday BUY SELL Signals
IMNN
Price
$3.15
Change
-$0.16 (-4.83%)
Updated
Dec 26 closing price
Capitalization
9.67M
Intraday BUY SELL Signals
Interact to see
Advertisement

ANEB vs IMNN

Header iconANEB vs IMNN Comparison
Open Charts ANEB vs IMNNBanner chart's image
Anebulo Pharmaceuticals
Price$1.12
Change-$0.08 (-6.67%)
Volume$132.53K
Capitalization46.01M
Imunon
Price$3.15
Change-$0.16 (-4.83%)
Volume$66.23K
Capitalization9.67M
ANEB vs IMNN Comparison Chart in %
ANEB
Daily Signal:
Gain/Loss:
IMNN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANEB vs. IMNN commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Hold and IMNN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (ANEB: $1.12 vs. IMNN: $3.15)
Brand notoriety: ANEB and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 241% vs. IMNN: 136%
Market capitalization -- ANEB: $46.01M vs. IMNN: $9.67M
ANEB [@Biotechnology] is valued at $46.01M. IMNN’s [@Biotechnology] market capitalization is $9.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANEB and IMNN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 4 TA indicator(s) are bullish while IMNN’s TA Score has 4 bullish TA indicator(s).

  • ANEB’s TA Score: 4 bullish, 5 bearish.
  • IMNN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMNN is a better buy in the short-term than ANEB.

Price Growth

ANEB (@Biotechnology) experienced а -48.39% price change this week, while IMNN (@Biotechnology) price change was -16.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

ANEB is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANEB($46M) has a higher market cap than IMNN($9.67M). ANEB YTD gains are higher at: -33.333 vs. IMNN (-74.579). ANEB has higher annual earnings (EBITDA): -8.1M vs. IMNN (-13.33M). ANEB has more cash in the bank: 10.4M vs. IMNN (5.25M). ANEB (0) and IMNN (0) have equivalent revenues.
ANEBIMNNANEB / IMNN
Capitalization46M9.67M476%
EBITDA-8.1M-13.33M61%
Gain YTD-33.333-74.57945%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.4M5.25M198%
Total DebtN/A1.1M-
FUNDAMENTALS RATINGS
IMNN: Fundamental Ratings
IMNN
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANEBIMNN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 19 days ago
71%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANEB
Daily Signal:
Gain/Loss:
IMNN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXSPF1.95N/A
N/A
EXPERT AI SPA
SSPPF2.50N/A
N/A
SSP Group PLC
BDULF0.61N/A
N/A
Bangkok Dusit Medical Services Public Co., Ltd.
PVFPF0.72N/A
N/A
Partners Value Invts LP
CNAF7.61-0.02
-0.26%
Commercial National Financial Corp. (PA)

ANEB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANEB has been loosely correlated with ABVX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANEB jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-6.67%
ABVX - ANEB
48%
Loosely correlated
-2.06%
TECX - ANEB
28%
Poorly correlated
-4.22%
ALDX - ANEB
28%
Poorly correlated
+0.57%
IMNN - ANEB
26%
Poorly correlated
-4.83%
BCTX - ANEB
26%
Poorly correlated
-4.33%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with ABVX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
-4.83%
ABVX - IMNN
58%
Loosely correlated
-2.06%
REPL - IMNN
57%
Loosely correlated
-1.29%
STOK - IMNN
30%
Poorly correlated
-0.78%
DNLI - IMNN
30%
Poorly correlated
-0.71%
DTIL - IMNN
29%
Poorly correlated
-1.40%
More